Related references
Note: Only part of the references are listed.Scutellarin Suppresses RPMI7951 Melanoma Cell Proliferation by Targeting TOPK
Xin Mu et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
TOPK mediates hypoxia-induced epithelial-mesenchymal transition and the invasion of nonsmall-cell lung cancer cells via the HIF-1α/snail axis
Jung-Hwan Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy
Jofer Andree Zamame Ramirez et al.
LIFE SCIENCES (2021)
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Ruijuan Du et al.
MOLECULAR CANCER (2021)
PBK/TOPK: A Therapeutic Target Worthy of Attention
Ziping Han et al.
CELLS (2021)
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
Xiong Zhang et al.
CANCERS (2021)
3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
Xiaorong Fu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
T-LAK cell-originated protein kinase (TOPK) enhances androgen receptor splice variant (ARv7) and drives androgen-independent growth in prostate cancer
Lama Alhawas et al.
CARCINOGENESIS (2021)
Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress
Katharine J. Herbert et al.
CELL DEATH AND DIFFERENTIATION (2021)
TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling
Young-Ju Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
TOPKi-NBD: a fluorescent small molecule for tumor imaging
Giacomo Pirovano et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models
Andrew T. Stefka et al.
CANCER MEDICINE (2020)
Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling
Gangping Hao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin (vol 19, 1264, 2019)
Yanan Jiang et al.
BMC CANCER (2020)
Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
Ran Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
PDZ-Binding kinase-Dependent Transcriptional Regulation of CCNB2 Promotes Tumorigenesis and Radio-Resistance in Glioblastoma
Ping Mao et al.
TRANSLATIONAL ONCOLOGY (2020)
Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032
Eunmiri Roh et al.
ONCOGENE (2020)
Activation of NF-κB by TOPK upregulates Snail/Slug expression in TGF-β1 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells
Young-Ju Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Autophosphorylation of EGFR at Y954 Facilitated Homodimerization and Enhanced Downstream Signals
Ovia M. Thirukkumaran et al.
BIOPHYSICAL JOURNAL (2020)
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
Pichaya Thanindratarn et al.
CELL PROLIFERATION (2020)
Anticancer property of ginsenoside Rh2 from ginseng
Xun Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer
Anne Y. Warren et al.
ONCOGENE (2019)
Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase
Lijuan Wang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase
Xin Diao et al.
BIOSCIENCE REPORTS (2019)
Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo
Xiaomeng Xie et al.
CANCER LETTERS (2019)
Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis
Tiantao Gao et al.
CANCER LETTERS (2019)
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation
Emi Uchida et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
Hanlin Ma et al.
CELL DEATH & DISEASE (2019)
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC
Adwitiya Kar et al.
ENDOCRINE-RELATED CANCER (2019)
Autophosphorylation activates c-Src kinase through global structural rearrangements
Edgar E. Boczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
Feifei Liu et al.
CANCER PREVENTION RESEARCH (2019)
Hyperoxidation of mitochondrial peroxiredoxin limits H2O2-induced cell death in yeast
Gaetano Calabrese et al.
EMBO JOURNAL (2019)
Glycyrol exerts potent therapeutic effect on lung cancer via directly inactivating T-LAK cell-originated protein kinase
Shangyun Lu et al.
PHARMACOLOGICAL RESEARCH (2019)
TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
Hui Lu et al.
CELL DEATH & DISEASE (2019)
Sulfasalazine suppresses thyroid cancer cell proliferation and metastasis through T-cell originated protein kinase
Ling Zou et al.
ONCOLOGY LETTERS (2019)
Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
Juanjuan Xiao et al.
CELL DEATH & DISEASE (2019)
Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase
Xiaoming Fan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK
Quan-Fang Hu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
[18F]FE-OTS964: a Small Molecule Targeting TOPK for In Vivo PET Imaging in a Glioblastoma Xenograft Model
Giacomo Pirovano et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer
Ran Zhao et al.
PHYTOMEDICINE (2019)
Ginsenoside Rh2 Suppresses Breast Cancer Cell Proliferation by Epigenetically Regulating the Long Noncoding RNA C3orf67-AS1
Dawoon Jeong et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma
Tomohide Hayashi et al.
NEUROPATHOLOGY (2018)
Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations
Michiya Sugimori et al.
ONCOTARGET (2018)
Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
Honglin Li et al.
BMC CANCER (2018)
A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses
Seung-Keun Hong et al.
CELLULAR SIGNALLING (2018)
Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma
Ka-Kui Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Mitotic kinase PBK/TOPK as a therapeutic target for adult T-cell leukemia/lymphoma
Chie Ishikawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Novel biomarker, phosphorylated T-LAK cell-originated protein kinase (p-TOPK) can predict outcome in primary central nervous system lymphoma
Masaki Koh et al.
NEUROPATHOLOGY (2018)
Targeting PRPK and TOPK for skin cancer prevention and therapy
Eunmiri Roh et al.
ONCOGENE (2018)
MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase
Yaqin Chai et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays
Tzu-Cheng Su et al.
PLOS ONE (2018)
CDK4-6 inhibitors in breast cancer: current status and future development
Joan Rou-En Choo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
Takuma Ohashi et al.
BRITISH JOURNAL OF CANCER (2017)
ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK
Ge Gao et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Development of small molecular compounds targeting cancer stem cells
Jae-Hyun Park et al.
MEDCHEMCOMM (2017)
Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase
Hyung Chul Lee et al.
CELL DEATH & DISEASE (2017)
Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase
Mengzhu Zheng et al.
ONCOTARGET (2017)
Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase
Peipei Xue et al.
ONCOTARGET (2017)
Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion
Min-Ah Seol et al.
ONCOTARGET (2017)
PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma
Yu-Feng Yang et al.
ONCOTARGET (2017)
The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis
Tatyana A. Zykova et al.
EBIOMEDICINE (2017)
miR-322 stabilizes MEK1 expression to inhibit RAF/MEK/ERK pathway activation in cartilage
Bjorn Bluhm et al.
DEVELOPMENT (2017)
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
Giacomo Pirovano et al.
BRITISH JOURNAL OF CANCER (2017)
miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase
Jun Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma
Takuma Ohashi et al.
ANTICANCER RESEARCH (2016)
T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer
Yuji Ikeda et al.
CLINICAL CANCER RESEARCH (2016)
Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation
Sumin Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation
Karina Smorodinsky-Atias et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun
Ying Li et al.
ONCOTARGET (2016)
Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon cancer
Juanjuan Xiao et al.
ONCOTARGET (2016)
Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase
Xiaoming Fan et al.
ONCOTARGET (2016)
Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase
Xiaoyu Zeng et al.
ONCOTARGET (2016)
PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival
Meng-Yao Wang et al.
ONCOTARGET (2016)
Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase
Xinhua Song et al.
ONCOTARGET (2016)
Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase
Jianjun Yang et al.
JOURNAL OF GINSENG RESEARCH (2016)
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
Chin-Fang Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
Xiaoyan Dou et al.
CANCER CELL INTERNATIONAL (2015)
Dynamic Phosphorylation of CENP-A at Ser68 Orchestrates Its Cell-Cycle-Dependent Deposition at Centromeres
Zhouliang Yu et al.
DEVELOPMENTAL CELL (2015)
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles of effective cancer therapy
Zutao Yu et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
Mrinal Joel et al.
MOLECULAR CANCER (2015)
PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis
Yuhong Liu et al.
ONCOLOGY REPORTS (2015)
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia
Houda Alachkar et al.
ONCOTARGET (2015)
TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
Huimin Sun et al.
ONCOTARGET (2015)
Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins
Raed Rizkallah et al.
ONCOTARGET (2015)
Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-κB activity in leukemia cells
Jung-Hwan Park et al.
CELLULAR SIGNALLING (2014)
TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis
Yo Matsuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
TOPK and PTEN participate in CHFR mediated mitotic checkpoint
Swapnil R. Shinde et al.
CELLULAR SIGNALLING (2013)
PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression
Bin Lei et al.
HISTOPATHOLOGY (2013)
c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas
Fang Hu et al.
LEUKEMIA RESEARCH (2013)
Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1
Gian Felice De Nicola et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth
Dong Joon Kim et al.
CANCER RESEARCH (2012)
Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma
Di-Cing Wei et al.
CANCER SCIENCE (2012)
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer
M-C Shih et al.
ONCOGENE (2012)
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells
Guangmin Xi et al.
CANCER LETTERS (2011)
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
Nam Joo Kang et al.
CARCINOGENESIS (2011)
T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of MKP1 Protein Prevents Solar Ultraviolet Light-induced Inflammation through Inhibition of the p38 Protein Signaling Pathway
Shengqing Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
I. Zlobec et al.
BRITISH JOURNAL OF CANCER (2010)
A Chemosensitization Screen Identifies TP53RK, a Kinase that Restrains Apoptosis after Mitotic Stress
David Peterson et al.
CANCER RESEARCH (2010)
Critical roles of T-LAK cell-originated protein kinase in cytokinesis
Jae-Hyun Park et al.
CANCER SCIENCE (2010)
PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells
Edita Aksamitiene et al.
CELLULAR SIGNALLING (2010)
Critical Roles of LGN/GPSM2 Phosphorylation by PBK/TOPK in Cell Division of Breast Cancer Cells
Chikako Fukukawa et al.
GENES CHROMOSOMES & CANCER (2010)
PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma
Furong He et al.
HUMAN PATHOLOGY (2010)
T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of Prx1 at Ser-32 Prevents UVB-induced Apoptosis in RPMI7951 Melanoma Cells through the Regulation of Prx1 Peroxidase Activity
Tatyana A. Zykova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
F. Hu et al.
ONCOGENE (2010)
Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target
D. Herrero-Martin et al.
BRITISH JOURNAL OF CANCER (2009)
A mitotic kinase TOPK enhances cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis
Yasuhito Abe et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT1 16 colorectal cancer cells
Feng Zhu et al.
GASTROENTEROLOGY (2007)
Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53
Asit K. Nandi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation
Sang-Muk Oh et al.
CANCER RESEARCH (2007)
TOPK promotes tumour cell proliferation through p38MAPK activity and regulation of the DNA damage response
V. Ayllon et al.
ONCOGENE (2007)
Lymphokine-activated killer T-cell-originated protein kinase. Phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells
Tatyana A. Zykova et al.
CLINICAL CANCER RESEARCH (2006)
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer
Jae-Hyun Park et al.
CANCER RESEARCH (2006)
Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF
AK Nandi et al.
LEUKEMIA RESEARCH (2006)
PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase
JD Dougherty et al.
JOURNAL OF NEUROSCIENCE (2005)
The Ras/Raf/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma
F Meier et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Characterization of a MAPKK-like protein kinase TOPK
S Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Mitotic regulation of the human anaphase-promoting complex by phosphorylation
C Kraft et al.
EMBO JOURNAL (2003)
Cancer chemoprevention with dietary phytochemicals
YJ Surh
NATURE REVIEWS CANCER (2003)
Regulation of growth-related genes by interleukin-6 in murine myeloma cells
S Côté et al.
CYTOKINE (2002)
Characterization of PDZ-binding kinase, a mitotic kinase
S Gaudet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
